age1

What they do

age1 is a venture capital firm focused on funding breakthrough longevity companies addressing the core challenges of the field. It backs exceptional founders in the US and globally who are developing therapeutics, tools, and technologies targeting aging and age-related disease to extend healthy lifespan. The firm invests at the earliest stages, often before any capital has been raised, and is building a pragmatic, rigorous, and optimistic longevity community.

What they look for

age1 invests in exceptional founders in the US and worldwide building therapeutics, tools, and technologies that target aging and age-related diseases to extend healthy lifespan. The firm focuses on the earliest stages of company formation, writing checks from $500,000 to $4 million and supporting portfolio companies through later rounds.

Stage

Ideation, Pre-seed, Seed, Series A, Series B+

Sectors

Healthcare

Based

San Francisco, US